Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy B Moelans

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Clinical & Experimental Metastasis|December 15, 2018
Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastasesQuirine F Manson, Willemijne A M E Schrijver, Natalie D Ter Hoeve, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 16, 2014
Validation of DNA promoter hypermethylation biomarkers in breast cancer--a short reportJolien S de Groot, Xiaojuan Pan, Jan Meeldijk, et al.
Cancers|January 11, 2022
Nipple Aspirate Fluid at a GlanceSusana I S Patuleia, Karijn P M Suijkerbuijk, Elsken van der Wall, et al.
International Journal of Molecular Sciences|November 23, 2019
Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and ManagementCathy B Moelans, Susana I S Patuleia, Carla H van Gils, et al.
Journal of the National Cancer Institute|April 5, 2018
Response to A. Matikas et alWillemijne A M E Schrijver, Karijn P M Suijkerbuijk, Elsken van der Wall, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 22, 2009
Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancerCathy B Moelans, Roel A de Weger, Marja T M van Blokland, et al.
Analytical Cellular Pathology (Amsterdam)|October 23, 2010
ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification studyCathy B Moelans, Hanneke N Monsuur, Johannes H de Pinth, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|March 6, 2010
Validation of a fully automated HER2 staining kit in breast cancerCathy B Moelans, Robby E Kibbelaar, Marius C van den Heuvel, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 5, 2011
ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification studyCathy B Moelans, Hanneke N Monsuur, Johannes H de Pinth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 7, 2018
Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplificationMirthe de Boer, Anoek H J Verschuur-Maes, Horst Buerger, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Clinical & Experimental Metastasis|December 15, 2018
Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastasesQuirine F Manson, Willemijne A M E Schrijver, Natalie D Ter Hoeve, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 16, 2014
Validation of DNA promoter hypermethylation biomarkers in breast cancer--a short reportJolien S de Groot, Xiaojuan Pan, Jan Meeldijk, et al.
Cancers|January 11, 2022
Nipple Aspirate Fluid at a GlanceSusana I S Patuleia, Karijn P M Suijkerbuijk, Elsken van der Wall, et al.
International Journal of Molecular Sciences|November 23, 2019
Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and ManagementCathy B Moelans, Susana I S Patuleia, Carla H van Gils, et al.
Journal of the National Cancer Institute|April 5, 2018
Response to A. Matikas et alWillemijne A M E Schrijver, Karijn P M Suijkerbuijk, Elsken van der Wall, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 22, 2009
Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancerCathy B Moelans, Roel A de Weger, Marja T M van Blokland, et al.
Analytical Cellular Pathology (Amsterdam)|October 23, 2010
ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification studyCathy B Moelans, Hanneke N Monsuur, Johannes H de Pinth, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|March 6, 2010
Validation of a fully automated HER2 staining kit in breast cancerCathy B Moelans, Robby E Kibbelaar, Marius C van den Heuvel, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 5, 2011
ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification studyCathy B Moelans, Hanneke N Monsuur, Johannes H de Pinth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 7, 2018
Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplificationMirthe de Boer, Anoek H J Verschuur-Maes, Horst Buerger, et al.
Pageof 8